Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
IAC Express
|
2017 Issues
|
Issue 1286
Issue 1286: January 18, 2017

Ask the Experts
Ask the Experts—Question of the Week: A dose of Kinrix (DTaP-IPV; GSK) should have been administered…read more


TOP STORIES


IAC HANDOUTS


VACCINE INFORMATION STATEMENTS


WORLD NEWS


FEATURED RESOURCES


JOURNAL ARTICLES AND NEWSLETTERS


EDUCATION AND TRAINING

 


TOP STORIES


Reminder: December issues of Needle Tips and Vaccinate Adults are available online

The December issues of Needle Tips and Vaccinate Adults are now available online. Vaccinate Adults is an abbreviated version of Needle Tips with the pediatric content removed. Both publications focus on ACIP recommendations for MenB and MenACWY vaccination, and also include information on the new 2-dose HPV recommendation. A number of related resources for healthcare providers, patients, and parents are provided, including updated standing orders templates and recommendation summaries for MenB and MenACWY.

Click on the images below to download the December issues (PDF) of Needle Tips and/or Vaccinate Adults.

Download the November issue of Needle TipsDownload the November issue of Vaccinate Adults

Needle Tips: View the Table of ContentsAsk the Experts section, magazine viewer, and back issues.

Vaccinate Adults: View the Table of ContentsAsk the Experts section, magazine viewer, and back issues.

If you would like to receive immediate email notification whenever new issues of Needle Tips or Vaccinate Adults are released, visit IAC's subscribe page to sign up.

Back to top


IAC's Ask the Experts Q&As on MMR and zoster vaccines newly updated

IAC and CDC experts recently reviewed and updated the Ask the Experts Q&As relating to Measles, Mumps, and Rubella (MMR) and Zoster (shingles)

Related Links

Back to top



CDC requests nominations for its Childhood Immunization Champion Awards

The CDC Childhood Immunization Champion Award is an annual award that recognizes individuals who make a significant contribution toward improving public health through their work in childhood immunization.
 
Each year, up to one CDC Immunization Champion from each of the 50 U.S. states, eight U.S. territories and freely associated states, and the District of Columbia will be honored. Champions can include coalition members, parents, healthcare professionals (e.g., physicians, nurses, physicians’ assistants, nurse practitioners, and medical assistants), and other immunization leaders who meet the award criteria. Self-nominations are welcome, or you may submit an application for a deserving individual.

Immunization program managers, state and federal government employees paid by state or federal immunization funding, individuals who have been affiliated with and/or employed by pharmaceutical companies, and those who have already received the award are not eligible to apply (for details, see page 3 of the nomination packet).

Awardees will be announced during National Infant Immunization Week (NIIW), which runs April 22–29 this year. Champions will receive a certificate of recognition, will be featured on CDC’s web site, and may be recognized by their immunization program during NIIW.

Nominations should be submitted to the Immunization Program Manager in the state or territory where the nominee resides by February 3. Please contact your state immunization program to confirm your state’s deadline. 

Related Links

Back to top


Nominations are now open for the National Adult and Influenza Immunization Summit Excellence Awards

The National Adult and Influenza Immunization Summit (NAIIS) is now soliciting nominations for the 2017 Immunization Excellence Awards. These prestigious awards recognize individuals and organizations that have made extraordinary contributions towards improving vaccination rates within their communities during 2016. The awards focus on individuals and organizations that exemplify the meaning of the "immunization neighborhood" (collaboration, coordination, and communication among immunization stakeholders dedicated to meeting the immunization needs of the patient and protecting the community from vaccine-preventable diseases).

The national winner in each category will be invited to present their program at the 2017 NAIIS meeting, to be held May 9–11 in Atlanta, Georgia. The deadline for receipt of nominations is February 24.

Nominations are being accepted for the following six award categories:     

  • NEW: Non-Healthcare Employer Campaign
  • Laura Scott NAIIS Immunization Excellence Award for Outstanding Influenza Season Activities Campaign
  • “Immunization Neighborhood” Champion
  • Adult Immunization Champion
  • Corporate Campaign
  • Adult Immunization Publication Award

Related Links

Back to top


CDC publishes guidance for assessment of poliovirus vaccination status and vaccination of children who have received polio vaccine outside the U.S.

CDC published Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States in the January 13 issue of MMWR (pages 23–5). A summary made available to the press is reprinted below.

This report highlights recent changes in the global polio eradication program strategies and provides guidance to ensure adequate vaccination of children who might have received poliovirus vaccination outside the U.S. This guidance is not new policy and does not change the current recommendations for poliovirus vaccination in the U.S. Children living in the U.S. who might have received poliovirus vaccination outside the U.S. should have protection against all three poliovirus types by age-appropriate vaccination with IPV or trivalent oral polio vaccine. In the absence of vaccination records indicating receipt of these vaccines, vaccination or revaccination with the age-appropriate U.S. IPV schedule is recommended. Serology to assess immunity for children with no or questionable documentation of poliovirus vaccination will no longer be an available option and is no longer recommended.

Related Links

Back to top


Professional organizations respond to President-elect Trump's meeting with Robert Kennedy Jr., regarding vaccine safety

On January 10, President-elect Trump met with vaccine conspiracy theorist Robert F. Kennedy Jr., who afterward claimed that Trump had asked him to chair “a commission on vaccination safety and scientific integrity.” Hours later, Trump transition spokeswoman Hope Hicks released a statement that read in part: “The President-elect is exploring the possibility of forming a commission on autism, which affects so many families; however no decisions have been made at this time." Kennedy is a well-known proponent of disproved theories regarding the safety of vaccines, especially the nonexistent link between vaccination and the development of autism.

Several professional organizations and individuals responded quickly to this news.

Back to top


American Academy of Pediatrics helps to change billing coding for vaccine administration

An article published in the December 30 issue of AAP News, AAP advocacy leads to change in coding for vaccine administration, provides details about an increase in the number of units of service allowed for vaccine administration. A section of the article is reprinted below.

The change affects code 90460 (Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered) and code 90461 (immunization administration through 18 years of age via any route of admin, w/ counseling by physician or other qualified health care professional; each additional component).

Medically unlikely edits (MUEs) are the daily limit placed by the Centers for Medicare & Medicaid Services (CMS) and often are used by private payers to reduce the likelihood of coding errors. MUEs are part of the National Correct Coding Initiative (NCCI) edit system.

 
For more information, read the complete article: AAP advocacy leads to change in coding for vaccine administration
 
Back to top


IAC enrolls four new birthing institutions into its Hepatitis B Birth Dose Honor Roll; five previously honored institutions qualify for additional years' honors

The Immunization Action Coalition (IAC) is pleased to announce that four new institutions have been accepted into its Hepatitis B Birth Dose Honor Roll. The birthing institutions are listed below with their reported hepatitis B birth dose coverage rates in parentheses.

  • Huron Medical Center, Bad Axe, MI (91%)
  • Jefferson Hospital, Jefferson Hills, PA (98%)
  • Odessa Regional Medical Center, Odessa, TX (98%)
  • Sunrise Children's Hospital, Las Vegas, NV (92%)

In addition, the following five institutions are being recognized for a second year:

  • INTEGRIS Grove Hospital, Grove, OK (98%)
  • MetroHealth Medical Center, Cleveland, OH (96%)
  • Montefiore Medical Center, Wakefield Campus, Bronx, NY (98%)
  • Seminole Memorial Hospital, Seminole, TX (95%)
  • UMass Memorial Medical Center, Worcester, MA (93%) 

The Honor Roll now includes 314 birthing institutions from 38 states, Puerto Rico, and Guam. One hundred institutions have qualified for two years, 35 institutions have qualified three times, 5 institutions have qualified four times, and 2 institutions have qualified five times.

The Honor Roll is a key part of IAC’s major initiative urging the nation’s hospitals to Give birth to the end of Hep B. Hospitals and birthing centers are recognized for attaining high coverage rates for administering hepatitis B vaccine at birth and meeting specific additional criteria. The initiative urges qualifying healthcare organizations to apply for the Hepatitis B Birth Dose Honor Roll online.

To be included in the Hepatitis B Birth Dose Honor Roll, a birthing institution must have: (1) reported a coverage rate of 90 percent or greater, over a 12-month period, for administering hepatitis B vaccine before hospital discharge to all newborns, including those whose parents refuse vaccination, and (2) implemented specific written policies, procedures, and protocols to protect all newborns from hepatitis B virus infection prior to hospital discharge.

Honorees are also awarded an 8.5" x 11" color certificate suitable for framing and their acceptance is announced to IAC Express’s approximately 50,000 readers.

Please visit the Hepatitis B Birth Dose Honor Roll web page that lists these institutions and their exceptional efforts to protect infants from perinatal hepatitis B transmission.

Related Links

Back to top


NVPO seeks information about business models that enable healthcare providers to offer vaccines to their privately insured/private-pay patients

The National Vaccine Program Office (NVPO) is seeking information about business models—existing, under development, or planned—that enable healthcare providers to offer vaccines to their privately insured/private-pay patients. NVPO is most interested in innovative business models aimed at reducing any of the barriers to implementing vaccination services such as vaccine purchase, billing, storage and handling, immunization information systems (IIS) reporting, including models for populating IIS directly/automatically from electronic medical records, forecasting vaccine demand, and managing private vaccine inventories. In addition, NVPO is interested in models that can demonstrate improvements in the immunization coverage rates of the patients seen in the healthcare settings utilizing such models as well as improvements in reporting to IIS.
 
If you have such information, please respond to this Federal Register Notice by January 25: Request for Information From Organizations Utilizing Business Models Supporting Private Sector Vaccine Management

This initiative is part of NVPO's efforts to promote vaccination coverage across the lifespan.
 
Back to top


IAC HANDOUTS


IAC adds more information to its human papillomavirus (HPV) vaccine standing orders templates

IAC recently added more information to its Standing Orders for  Administering Human Papillomavirus Vaccine to Children and Teens to make clear that a 3-dose HPV vaccine schedule is recommended for people age aged 9 through 26 who have primary and secondary immunocompromising conditions, regardless of age at initiation of the series.

IAC revised its Standing Orders for Administering Human Papillomavirus Vaccine to Adults to allow for a 2-dose schedule in those adults who may have received their first dose before their 15th birthday.

Related Links

  • IAC's Standings Orders web page for all templates
  • IAC's Handouts for Patients & Staff web section offers healthcare professionals and the public more than 250 FREE English-language handouts (many also available in translation), which we encourage website users to print out, copy, and distribute widely

Back to top


VACCINE INFORMATION STATEMENTS


MMR VIS now available in Ilokano and Chuukese languages

IAC recently posted Ilokano and Chuukese translations of the MMR VIS. IAC thanks the Hawaii Department of Health for the translations.

Related Links

Back to top


Rotavirus, Tdap, and Td VISs now available in Japanese

IAC recently posted Japanese translations of the Tdap, Td, and Rotavirus VISs. IAC thanks the Oregon Health Authority for the translations.

Related Links

Back to top


WORLD NEWS


Weekly Epidemiological Report publishes summary of Global Advisory Committee on Vaccine Safety meeting

WHO published Global Advisory Committee on Vaccine Safety, 30 November–1 December 2016 in the January 13 issue of the Weekly Epidemiological Record. The first paragraph is reprinted below.
 
The Global Advisory Committee on Vaccine Safety (GACVS), an independent expert clinical and scientific advisory body, provides WHO with scientifically rigorous advice on vaccine safety issues of potential global importance. GACVS held its 35th meeting in Geneva, Switzerland, on 30 November and 1 December 2016. The Committee examined 2 generic issues: updates on its operations following a review conducted in 2014, and progress with developing the Vaccine Safety Net. It also reviewed vaccine-specific safety issues concerning typhoid vaccines, yellow fever vaccines and new data examining the relationship between the occurrence of narcolepsy and administration of p2009H1N1 monovalent vaccines.


Related Links

Back to top


FEATURED RESOURCES


2017 supplement to the 13th edition of the Pink Book is now available online

CDC has announced that a 2017 supplement to the 13th edition of the textbook Epidemiology and Prevention of Vaccine-Preventable Diseases, also known as "The Pink Book," is now available. The supplement reflects the latest ACIP recommendations since the latest publication of the Pink Book in 2015, including additional information on human papillomavirus vaccine, meningococcal vaccines, and pneumococcal vaccines. 

Visit www.cdc.gov/vaccines/pubs/pinkbook/supplement.html to view and/or download your copy of the 2017 supplement. 

The 13th edition of the Pink Book is available for purchase from the PHF Learning Resource Center or can be viewed/downloaded online at no charge.

Back to top


Influenza is spreading and serious; please keep vaccinating your patients

Influenza vaccination is recommended for everyone six months of age and older. If you don't provide influenza vaccination in your clinic, please recommend vaccination to your patients and refer them to a clinic or pharmacy that provides vaccines or to the HealthMap Vaccine Finder to locate sites near their workplaces or homes that offer influenza vaccination services.

Following is a list of resources related to influenza disease and vaccination for healthcare professionals and the public:

Back to top


JOURNAL ARTICLES AND NEWSLETTERS


New study shows childhood vaccination to be a highly cost-effective medical intervention 

Updated Priorities Among Effective Clinical Preventive Services, published in the Annals of Family Medicine, found childhood vaccinations to be one of the most cost-effective medical interventions. Sections of the abstract are reprinted below.

Purpose
The Patient Protection and Affordable Care Act’s provisions for first-dollar coverage of evidence-based preventive services have reduced an important barrier to receipt of preventive care. Safety-net providers, however, still serve a substantial uninsured population, and clinician and patient time remain limited in all primary care settings. As a consequence, decision makers continue to set priorities to help focus their efforts. This report updates estimates of relative health impact and cost-effectiveness for evidence-based preventive services.

Methods
We assessed the potential impact of 28 evidence-based clinical preventive services in terms of their cost-effectiveness and clinically preventable burden, as measured by quality-adjusted life years (QALYs) saved...

Results
The 3 highest-ranking services, each with a total score of 10, are immunizing children, counseling to prevent tobacco initiation among youth, and tobacco-use screening and brief intervention to encourage cessation among adults...

Conclusions
This study identifies high-priority preventive services and should help decision makers select which services to emphasize in quality-improvement initiatives.

Back to top


January's Parents PACK newsletter from VEC includes HPV information for parents 

Parents PACK (Possessing, Accessing, and Communicating Knowledge about vaccines) from the Children's Hospital of Philadelphia offers an electronic newsletter for parents. The January issue features resources about human papillomavirus (HPV) infection and vaccination. Healthcare providers should check out the issue and encourage parents to subscribe to the free Parents PACK newsletter.

To find more information about their resources or to subscribe to this newsletter, visit the Parents PACK web page.

Related Links

Back to top


EDUCATION AND TRAINING


CDC offers Medscape Expert Commentary about 2016–2017 influenza antiviral recommendations
 
Medscape recently posted 2016–2017 Influenza Antiviral Recommendations, as part of CDC's Expert Commentary Series. There is no cost to view this video on Medscape, but you must register.
 
Related Link
HepB United to sponsor webinar on January 25 about using health information technology to identify and manage disparities in high-risk populations
 
HepB United will sponsor a 1-hour webinar on January 25 at 3:00 p.m. (ET) titled "Strategies for Using Health Information Technology to Identify and Manage Disparities in High Risk Populations." Participants in this interactive session will learn about a community health center-based health information technology and electronic health record system designed to increase hepatitis B screening, vaccination, and treatment. Panelists will also discuss a pilot project that examines the collection of non-clinical or social determinants of health data and the potential impact on patients living with hepatitis B.

Related Link

Back to top 


NFID Spring Clinical Vaccinology Course scheduled for March 10–12 in Chicago
 
The National Foundation of Infectious Diseases (NFID) Spring 2017 Clinical Vaccinology Course will be held March 10–12 in Chicago. This 2.5-day course focuses on new developments and issues related to the use of vaccines. Expert faculty provide the latest information on vaccines, including updated recommendations for vaccinations across the lifespan, and innovative and practical strategies for ensuring timely and appropriate immunization. Continuing education credit is available for attendees.

Related Link

Back to top 


ASK THE EXPERTS

Question of the Week

A dose of Kinrix (DTaP-IPV; GSK) should have been administered to a 4-year-old, but Pentacel (DTaP-IPV-Hib; Sanofi Pasteur) was administered instead. Does the dose of DTaP count?   

Yes. The DTaP in the Pentacel can be counted. Although Pentacel is licensed as a 4-dose series and this may represent a fifth dose of Pentacel (in which case it would be off-label use), the dose of DTaP counts as the fifth dose of DTaP.


About IAC's Question of the Week

Each week, IAC Express highlights a new, topical, or important-to-reiterate Q&A. This feature is a cooperative venture between IAC and CDC. William L. Atkinson, MD, MPH, IAC's associate director for immunization education, chooses a new Q&A to feature every week from a set of Q&As prepared by experts at CDC’s National Center for Immunization and Respiratory Diseases.

We hope you enjoy this feature and find it helpful when dealing with difficult real-life scenarios in your vaccination practice. Please encourage your healthcare professional colleagues to sign up to receive IAC Express at www.immunize.org/subscribe.

If you have a question for the CDC immunization experts, you can email them directly at nipinfo@cdc.gov. There is no charge for this service.

Related Links

Back to top

About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue.

If you have trouble receiving or displaying IAC Express messages, visit our online help section.

IAC Express is supported in part by Grant No. 6NH23IP922550 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: AstraZeneca, Inc.; bioCSL Inc.; Merck Sharp & Dohme Corp.; Pfizer, Inc.; and Sanofi Pasteur.
IAC Express Disclaimer
ISSN: 1526-1786

Our mailing address is
Immunization Action Coalition
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114

Copyright (C) 2016 Immunization Action Coalition
All rights reserved.
Subscribe Today: IAC Express, Needle Tips, and Vaccinate Adults: the up-to-date immunization information you need
IAC Express
IAC Express Home
2017 Issues
2016 - 1997 Issues
immunize.org homepage
Shop IAC
Make a Donation
Follow Us
Follow IAC on Facebook
Follow IAC on Twitter
Follow IAC on YouTube
Video of the Week
Expert Panel Discussion: Achieving Childhood Vaccination Success in the US: The National Meningitis Association hosted this 90-minute panel discussion in May 2016, where six national immunization experts discuss vaccine concerns. Topics such as parent and healthcare provider resistance, media concerns, and laws and mandates were covered by the panel.
Visit the VOTW archive
Protect Newborns Guidebook
Protect Newborns Guidebook
Comprehensive guide Hepatitis B: What Hospitals Need to Do to Protect Newborns
IAC's Free Publications
Subscribe to IAC's Free Publications!
Up-to-date immunization information, practice oriented, and CDC reviewed. Sign up today!
Patient Record Cards
Purchase IAC's patient record cards today!
Record cards for patients -- child & teen, adult, and lifetime -- are printed on durable paper and sized to fit in a wallet when folded
DVD Immunization Techniques
Purchase Immunization Techniques DVD
Every practice should have this award winning, "how-to" training video
The Vaccine Handbook (Purple Book)
Order a copy of this practical guide today!
Order your copy today!
New App available at iTunes
Calendar of Events
Conferences, meetings, and training opportunities
Conferences, meetings, and training opportunities
Technically Speaking
Read Dr. Wexler's monthly column for practical advice on vaccination topics
Read Dr. Wexler's column for the Vaccine Education Center's monthly newsletter, Vaccine Update
Editorial Information
Editor: Deborah L. Wexler, MD
Managing Editor: Teresa Anderson, DDS, MPH
Consulting Editor: Marian Deegan, JD
Assistant Managing Editor: Liv Augusta Anderson, MPP
Issue Abbreviations
AAFP: American Academy of Family Physicians
AAP: American Academy of Pediatrics
ACIP: Advisory Committee on Immunization Practices
CDC: Centers for Disease Control and Prevention
FDA: Food and Drug Administration
IAC: Immunization Action Coalition
MMWR: Morbidity and Mortality Weekly Report
NCIRD: National Center for Immunization and Respiratory Diseases
VIS: Vaccine Information Statement
WHO: World Health Organization
 
 
- Guide to immunize.org -
A-Z INDEX
ABOUT IAC
ACIP RECOMMENDATIONS
ADDITIONAL RESOURCES
ADULT VACCINATION
ADULT VACCINATION GUIDE
ASK THE EXPERTS
Combination Vaccines
Diphtheria
Hepatitis A
Hepatitis B
Vaccine Storage and Handling
>> view all
BILLING & CODING
BIRTH DOSE GUIDEBOOK
CALENDAR
CDC INFORMATION
CDC SCHEDULES
CLINIC TOOLS
Administering Vaccines
Documenting Vaccination
Scheduling Vaccination
Screening for Contraindications
Storage & Handling
Vaccine Recommendations
>> view all
COALITIONS
CONTRIBUTE TO IAC
DEAR COLLEAGUE LETTER
HPV VACCINE
DEAR COLLEAGUE LETTER
MCV4 DOSE #2
DISEASES & VACCINES
Diphtheria
Hepatitis A
Hepatitis B
Influenza
Varicella
>> view all
DONATE TO IAC
EMAIL NEWS SERVICES
EDUCATIONAL MATERIALS
FAQs
FAVORITES (WEB SECTIONS)
FDA PRODUCT APPROVALS
GIVE BIRTH TO THE END OF
HEP B
HANDOUTS FOR PATIENTS &
STAFF
Administering Vaccines
Adult Vaccination
Documenting Vaccinations
Managing Vaccine Reactions
Parent Handouts
Patient Schedules
Questions & Answers
Recommendations
Screening Checklists
Standing Orders
Storage & Handling
Talking with Parents
Temperature Logs
Top Handouts
Translations
Vaccine Index
>> view all
HEPATITIS B BIRTH DOSE
HONOR ROLLS
HepB Birth Dose
Influenza Vaccination for HCP
IAC EXPRESS
IMAGES
IMMUNIZATION TECHNIQUES
DVD
LAMINATED SCHEDULES
LAWS AND MANDATES
MANUFACTURERS
NATIONAL ADULT & INFLUENZA IMMUNIZATION SUMMIT
NEWS & INFORMATION
OFFICIAL RELEASES
ACIP
CDC
FDA
>> view all
PACKAGE INSERTS
PARTNERS
PHARMACISTS
PHOTOS
POWERPOINT SLIDE SETS
PRESS ROOM
PROTECT NEWBORNS
FROM HEP B
PUBLICATIONS
IAC Express
REGISTRIES
RESOURCE DIRECTORY
SHOP IAC
Immunization Techniques DVD
Laminated Schedules
Patient Record Cards
>> view all
SITE MAP
SLIDE SETS
STANDING ORDERS TEMPLATES
STATE INFORMATION
State Websites
State Laws
State Immunization Managers
>> view all
SUBSCRIBE
SUPPORT IAC
TECHNICALLY SPEAKING
TIMELINE FOR VACCINES
TRANSLATE FOR IAC
TRAVEL (INTERNATIONAL)
UNPROTECTED PEOPLE REPORTS
Chickenpox
Diphtheria
Hepatitis A
Hepatitis B
>> view all
VACCINATING ADULTS: A STEP-BY-STEP GUIDE
VACCINE CONCERNS
Adjuvants & Ingredients
Alternative Medicine
Autism
Importance of Vaccination
>> view all
VACCINE INFORMATION STATEMENTS
Translations
Vaccine Index
>> view all
VACCINE MANUFACTURERS
VACCINE POLICY & LICENSURE
ACIP
FDA
WHO
>> view all
VACCINE SAFETY
VACCINE TIMELINE
VACCINES & DISEASES
VIDEOS (VIDEO OF THE WEEK)
WHAT'S NEW OR UPDATED AT IAC
Handouts
VISs
Web Sections
>> view all
 
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
 
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 6NH23IP22550) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.